RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
about
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinomaAssessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTCGene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis.Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlationThyroid cancer: current molecular perspectives.Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.Loss of CCDC6 affects cell cycle through impaired intra-S-phase checkpoint controlMolecular rearrangements and morphology in thyroid cancer.Recent developments in the investigation of thyroid regulation and thyroid carcinogenesisRecent advances in molecular diagnosis of thyroid cancer.Genetic and biological subgroups of low-stage follicular thyroid cancerRET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma.Thyroid cancer: pathogenesis and targeted therapyNew treatment in advanced thyroid cancer.Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.Gene rearrangement and Chernobyl related thyroid cancers.Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.Essential genes in thyroid cancers: focus on fascin.What is New on Thyroid Cancer BiomarkersMolecular pathology of thyroid cancer: diagnostic and clinical implications.Biological complexities in radiation carcinogenesis and cancer radiotherapy: impact of new biological paradigms.Central role of RET in thyroid cancer.Thyroid Cancer: Role of RET and Beyond.miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.Genetics of papillary thyroid cancer initiation: implications for therapyNuclear envelope irregularity is induced by RET/PTC during interphase.Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.BRAF V600E and RET/PTC Promote the Activity of Nuclear Factor-κB, Inflammatory Mediators, and Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Study of 50 Patients in Inner Mongolia
P2860
Q24669934-35F0D54C-F751-4C86-8A5E-313ACACD405CQ31074050-C16CD871-410C-447F-9205-22A96349D053Q33337251-E71F8FB5-5DED-4E85-A7E1-FB6BB7F98835Q33357290-00F922E1-6D14-447F-B586-9AD884CABBE0Q33363441-38D198D5-A0C0-4605-9C24-702611037756Q33599429-D5ADD4E4-7E00-4B8A-9DB4-3A6B23695646Q33760910-F74A3FFD-43A2-4A74-807A-15491D0EAD34Q34078370-6F2140A8-AB49-4E85-9448-5F6348104AB3Q34170428-45BBB3AD-108D-4B4E-A8EC-C39558986C50Q34679424-D7CCEBD4-9C64-4EB1-AA38-6EF5F8D4E2A6Q34939295-15689164-F7CB-4F73-8EFA-FBDE23A34597Q34985320-FAE3A4FB-7FB4-4F47-B612-D66890C68798Q35749248-6184830B-5EF7-44EE-9501-86A23D797184Q35971877-90C7DC6D-0606-462D-ACF7-26C4AB296EFBQ35977327-CBF66EBA-4444-4705-A9DA-6AA3C071BADAQ36328045-2B10D757-64AA-44E5-A9E6-ACE16ABFF4AEQ36361115-C9E43CFD-938A-4593-93F5-2B0078D181FEQ36621089-2E942AF6-3783-41ED-8606-65087377F0EDQ36621093-41419260-D676-4A5F-AFAA-7DDFBA96D0A8Q36623366-00CA1512-7FD0-424B-BF7B-339F452214CBQ37071818-D47A8D1D-381A-4C04-91B4-D1A3314C447CQ37207279-5CF5E028-B850-4754-BAD6-752C5346B3FFQ37337504-FF1F65E0-D849-41C9-84CA-25782E68C194Q37508129-AC3B0070-02C2-4BCE-B287-6BA7F16FA02EQ38167995-FD81ED08-CB10-41E2-BD5C-557CBD363787Q38208316-1A118282-8DA1-4A99-99FC-E473437D80CCQ40720717-0D7EE9C1-0E0B-45A5-BE1C-E6D4501C229EQ41908055-CBC19D6F-0539-4DFD-BC48-CF8896E4B8D0Q42792243-3671A640-D2A5-4620-86C6-FA069981DC4FQ42824777-7639C5FE-CF5C-4647-BDC7-A4A131041C15Q58693775-06683F79-9F25-41F5-9657-958E5F4949BE
P2860
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@en
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@nl
type
label
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@en
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@nl
prefLabel
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@en
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@nl
P2093
P1433
P1476
RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
@en
P2093
Chiappetta G
Fukunaga FH
Martinez-Tello FJ
Rigopoulou D
Viglietto G
Visconti R
P304
P407
P577
1995-09-01T00:00:00Z